AFP and hepatocellular carcinoma: In three different mouse models with ectopic, orthotopic or carcinogen-induced HCC tumors that displayed antigenic and pathological heterogeneity, Lu et al. [168] showed that ExVs derived from α-fetoprotein (AFP)-expressing DCs elicited strong antigen-specific immune responses resulting in a significant tumor growth retardation and prolonged survival.